spacer

CDC HomeHIV/AIDS > Topics > Statistics and Surveillance > Guidelines > Integrated Guidelines for Developing Epidemiologic Profiles > Sample

Sample: Integrated Epidemiologic Profile for HIV/AIDS Prevention and Care Planning–Louisiana, 2002
space
arrow Acknowledgements
space
arrow List of Figures
space
arrow List of Tables
space
arrow Executive Summary
space
arrow Introduction
space
arrow Section 1
space
arrow Section 2
space
arrow Appendixes
space
arrow Glossary
space
arrow Abbreviations
space
 
LEGEND:
PDF Icon   Link to a PDF document
Non-CDC Web Link   Link to non-governmental site and does not necessarily represent the views of the CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
spacer spacer
spacer
Skip Nav spacer
List of Tables
spacer
spacer
  1. Percentage distribution of the general population, by age group and sex, Louisiana, 2000
  2. Percentage distribution of the general population, by race/ethnicity and sex, Louisiana, 2000
  3. Percentage distribution of the general population, by race/ethnicity and public health region, Louisiana, 2000
  4. Percentage distribution of the general population, by race/ethnicity for parishes of >250,000 population compared with population of Louisiana, 2000
  5. Percentage distribution of persons living below the poverty level during the past 12 months, by sex and age group, for parishes of >250,000 population, Louisiana, 2000
  6. Percentage distribution of the population 25 years or older, by educational attainment and sex, for parishes of >250,000 population, Louisiana, 2000
  7. Percentage distribution of adults (19–64 years), by health insurance coverage and sex, Louisiana, 1999–2000
  8. Characteristics of persons infected with HIV (HIV/AIDS), Louisiana, 2001
  9. HIV diagnoses and rates, by race/ethnicity and sex, Louisiana, 2001
  10. HIV diagnoses, by age group and sex, Louisiana, 2001
  11. Risk characteristics of persons with HIV infection (HIV/AIDS), Louisiana, 2001
  12. HIV diagnoses, by exposure category and race/ethnicity, Louisiana, 2001
  13. HIV diagnoses, by exposure category and sex, Louisiana, 2001
  14. Characteristics of persons with AIDS, Louisiana, 2001
  15. Characteristics of persons with AIDS who died and persons living with AIDS, Louisiana, 2001
  16. Deaths due to HIV infection or AIDS, by race and sex, Louisiana, 2000
  17. Persons living with AIDS, by race and sex, Louisiana, 2000
  18. Comparative ranking of 10 leading underlying causes of death of black persons and white persons aged 25–44 years, Louisiana, 1999
  19. Sexual risk behavior of persons aged 18–49 years in the general population, Behavioral Risk Factor Surveillance System, 2001
  20. Sexual risk behavior in high-risk populations, Street Outreach Survey, Louisiana, 2001
  21. HIV testing in the general population, Behavioral Risk Factor Surveillance System, Louisiana, 2001
  22. Six most commonly listed reasons for HIV testing, general population (n=678), Behavioral Risk Factor Surveillance System, Louisiana, 2001
  23. Locations of HIV testing, general population (n=670), Behavioral Risk Factor Surveillance System, Louisiana, 2001
  24. Percentages of high-risk populations ever tested for HIV, HIV Testing Survey, Louisiana, 2001
  25. HIV testing of high-risk persons (n=5,665), Street Outreach Survey, Louisiana, 2001
  26. HIV counseling and testing data, by demographics and type of test, Louisiana, 2001
  27. Comparison of demographic characteristics of CARE Act Title II clients and persons living with HIV/AIDS, Louisiana, 2001
  28. Utilization of Ryan White Title II service, by type of service (N=4,125), Louisiana, 2001
  29. Characteristics of patients enrolled in the AIDS Drug Assistance Program (N=1,440), Louisiana, June 2001
  30. Prescription of antiretroviral therapy (ART) and highly active antiretroviral therapy (HAART) for HIV-infected patients, by sex, race/ethnicity, and insurance status, Survey of HIV Disease and Care, Louisiana, 1998
  31. Current prescription of prophylaxis for Pneumocystis carinii pneumonia in HIV-infected patients, by sex, race/ethnicity, and insurance status, Survey of HIV Disease and Care, Louisiana, 1998
  32. Current prescription of highly active antiretroviral therapy (HAART) in HIV-infected patients, by sex and race/ethnicity, Adult/Adolescent Spectrum of Disease Project (N = 1,695), New Orleans, 2000
  33. Prescription of prophylaxis for primary Pneumocystis carinii pneumonia in HIV-infected patients, by sex and race/ethnicity, Adult/Adolescent Spectrum of Disease Project (N = 945), New Orleans, 2000
  34. Prescription of prophylaxis for Mycobacterium avium complex in HIV-infected patients, by sex and race/ethnicity, Adult/Adolescent Spectrum of Disease Project (N = 449), New Orleans, 2000
  35. Proportions of persons with AIDS diagnosis, by time between first positive HIV test result and AIDS diagnosis (N = 6,956), Louisiana, 1996–2000
Last Modified: July 18, 2007
Last Reviewed: July 18, 2007
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
spacer CDC Black Logospacer Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov
spacer
spacerHHS Logo